Solesence (SLSN) EBIAT (2016 - 2025)
Solesence (SLSN) has disclosed EBIAT for 16 consecutive years, with -$1.1 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, EBIAT fell 136.78% year-over-year to -$1.1 million, compared with a TTM value of $1.1 million through Sep 2025, down 59.9%, and an annual FY2024 reading of $4.2 million, up 196.47% over the prior year.
- EBIAT was -$1.1 million for Q3 2025 at Solesence, down from $2.7 million in the prior quarter.
- Across five years, EBIAT topped out at $3.0 million in Q3 2024 and bottomed at -$2.1 million in Q4 2023.
- Average EBIAT over 5 years is $61578.9, with a median of $50000.0 recorded in 2022.
- The sharpest move saw EBIAT surged 884.43% in 2021, then plummeted 1969.35% in 2023.
- Year by year, EBIAT stood at -$394000.0 in 2021, then crashed by 403.81% to -$2.0 million in 2022, then decreased by 7.2% to -$2.1 million in 2023, then skyrocketed by 73.78% to -$558000.0 in 2024, then tumbled by 100.72% to -$1.1 million in 2025.
- Business Quant data shows EBIAT for SLSN at -$1.1 million in Q3 2025, $2.7 million in Q2 2025, and $80000.0 in Q1 2025.